Clinical protocol. A phase 1 open-label clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects.

Human gene therapy

Volumn 12, Issue 16, 2001, Pages 2028-2029

  MacGregor, R R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; GENE VECTOR; GENETIC TRANSDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MIDDLE AGED; PHASE 1 CLINICAL TRIAL;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; GENETIC VECTORS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TRANSDUCTION, GENETIC;

EID: 0035513970     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)